Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.23.1
Revenue from Contracts with Customers (Tables)
6 Months Ended
Mar. 31, 2023
Revenue from Contracts with Customers [Abstract]  
Revenue from Customers by Products

Three Months Ended

Six Months Ended

March 31,

March 31,

2023

2022

2023

2022

FC2

U.S. prescription channel

$

4,146,160

$

11,590,466

$

4,309,164

$

23,164,732

Global public health sector

2,434,287

1,437,928

4,771,284

3,998,794

Total FC2

6,580,447

13,028,394

9,080,448

27,163,526

ENTADFI

5,520

13,313

Net revenues

$

6,585,967

$

13,028,394

$

9,093,761

$

27,163,526

Revenue by Geographic Area

Three Months Ended

Six Months Ended

March 31,

March 31,

2023

2022

2023

2022

United States

$

4,787,258

$

11,846,960

$

5,596,635

$

23,755,485

South Africa

1,328,400

*

1,329,678

*

Other

470,309

1,181,434

2,167,448

3,408,041

Net revenues

$

6,585,967

$

13,028,394

$

9,093,761

$

27,163,526

*Less than 10% of total net revenues